CS Medica is a Danish MedTech company, dedicated to pharmaceutical research, development, manufacturing, and worldwide commercialization. The company blends science and nature to improve patients' lives with cannabinoid therapies for pain relief and addressing autoimmune and stress-related symptoms. Globally, CS Medica offers over-the-counter (OTC) CBD treatments, including patented medical products, MHRA, and MDR-registered items, marketed under the brand CANNASEN® or with its own labeling.

Quotes for CS MEDICA A/S

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Lone Henriksen

Chairperson of the Board

  • Flemming Heegaard

Board

  • Anders Permin
  • Gitte Lund Henriksen
  • Ib Madsen
  • Jesper Herold Halle

Largest Owners

Name Capital % Votes % Date
Lone Henriksen 30,43 30,43 2024-11-12
Gitte Henriksen 29,60 29,60 2024-11-12
Finn-Ove Henriksen and Nina Henriksen 4,01 4,01 2024-11-12
Diaz Capital Invest AB 3,16 3,16 2022-08-24
Ylber Rexhepi 2,32 2,32 2022-06-30
Tonoy Sayeed 1,46 1,46 2022-06-30
Michael Kaa Andersen 1,18 1,18 2022-06-30
Tobias Ryde 1,10 1,10 2022-06-30
Kent Eklund 1,03 1,03 2022-06-30
Taulant Bara 1,03 1,03 2022-06-30

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream